Navigation Links
CryoLife Announces Additions to Management Team
Date:10/30/2007

ATLANTA, Oct. 30 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced today that Scott B. Capps has been named vice president, clinical research, effective October 29, 2007. Mr. Capps has served as vice president and general manager of CryoLife Europa, Ltd., based in the U.K., since February 2005.

Mr. Capps joined CryoLife in 1995 and has held several positions with the Company including project director for heart valves, director of clinical research and director of European clinical affairs. He is a graduate of the Georgia Institute of Technology and holds a Master's degree in bioengineering from Clemson University.

In a related move, David N. Hollinworth, Ph.D., has joined the company as vice president and general manager of CryoLife Europa, Ltd., effective October 29, 2007. Previously, Dr. Hollinworth held various management positions including chief executive officer of Chameleon Biosurfaces, European cardiology marketing manager of Siemens Medical and European market development manager in cardiology at Medtronic. Dr. Hollinworth holds a Ph.D. in biochemistry from The University of Bristol and an M.B.A. from the London Business School.

"Scott did a terrific job for CryoLife Europa, and we are very excited about tapping into the expertise he gained while there. His experiences with CryoLife, both in Europe and stateside, make him well qualified to lead our clinical operations here," said Steven G. Anderson, president and CEO of CryoLife, Inc. "I am also very pleased to welcome Dr. Hollinworth as general manager of CryoLife Europa. His extensive background in the marketing of new technologies and products will be of great assistance in the introduction of our new product pipeline in the years ahead."

About CryoLife, Inc.

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the United States and Canada. The Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoLife-O'Brien(R) stentless porcine heart valve, which is CE marked for distribution within the European Community. For additional information about the company, visit CryoLife's Web site:

http://www.cryolife.com

CryoLife Media Contacts:

D. Ashley Lee

Executive Vice President, Chief Operating Officer and

Chief Financial Officer

CryoLife, Inc.

Phone: 770-419-3355

Katie Brazel

Fleishman-Hillard

Phone: 404-739-0150


'/>"/>
SOURCE CryoLife, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... ... April 22, 2017 , ... ... consumers can save an average of 70% when buying medication online from Canadian ... are available when purchasing from other countries. The report (chart below) compares U.S. ...
(Date:4/21/2017)... ... , ... An April 10 article in the Daily Mail describes ... great deal about prehistoric ice-age dental practitioners and their primitive and, no doubt, painful ... decayed dental matter, and that teeth were then filled with bitumen, a substance similar ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... Christopher Salas-Wright finds that youth violence is declining—and at noteworthy rates. Between 2002 ... proportion of young people involved in violence in the United States. The study, ...
(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), ... its B-595 and B-7569 vinyl label materials received certification for ... labels are tested to remain intact and legible, for use on chemical drums shipped ...
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t tell” applies perfectly ... in the company’s esteemed VISION House demonstration project series. Manifesting the concept of right-sized ... resources they need to live affordably and abundantly without unduly taxing the resources of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), By ... 2014 - 2025" report to their offering. ... The Latin American pharmaceutical contract ... by 2025 Low drug registration cost in Latin ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most attractive market ... period Mobile X-Ray segment is the largest segment ... market, which is estimated to be valued at more than ... 7% over the forecast period. Mobile X-Ray segment is expected ... Mn in 2017 over 2016. The segment,s revenue in the ...
(Date:4/19/2017)... , April 19, 2017 Global Prostate ... report on the prostate cancer therapeutics market analyzes ... market. Increasing prevalence of prostate cancer, launch of ... the development of new drugs & therapeutic biological ... drug due to lesser side effects are some ...
Breaking Medicine Technology: